COVID-19 Vaccines: Ensuring Regulatory and Scientific Integrity During the Approval Process

COVID-19 Vaccines: Ensuring Regulatory and Scientific Integrity During the Approval Process

Policy Brief

COVID-19 Vaccines: Ensuring Regulatory and Scientific Integrity During the Approval Process

Published date

October 22, 2020

Duke-Margolis Affiliated Authors

Image of Nicholas Harrison

Nicholas R. Harrison, MPH, MA

Policy Research Associate

William K. Bleser - Margolis headhot

William K. Bleser, PhD, MSPH

Research Director, Health Care Transformation for Social Needs and Health Equity
Senior Team Member
Anti-Racism and Equity Committee Member

Morgan Romine headshot

Morgan Romine, MPA

Chief of Staff
Senior Team Member

Mark McClellan

Mark McClellan, MD, PhD

Director of the Duke-Margolis Institute for Health Policy
Robert J. Margolis, MD, Professor of Business, Medicine and Policy
Margolis Executive Core Faculty